Neochem Bio Solutions Limited (NSE:NEOCHEM)
India · Delayed Price · Currency is INR 97.30
+3.40 (3.62%)
At close: Sep 8, 2026
Neochem Bio Solutions Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1.81 | 0.55 | 3.51 | 0.48 | - |
Cash & Short-Term Investments | 1.81 | 0.55 | 3.51 | 0.48 | - |
Cash Growth | 229.09% | -84.33% | 626.85% | - | - |
Accounts Receivable | 487.23 | 252.77 | 167.38 | 144.15 | - |
Other Receivables | 48.77 | 23.89 | 0.18 | 2.79 | - |
Receivables | 544.86 | 286.27 | 177.36 | 149.73 | - |
Inventory | 292.54 | 237.56 | 182.1 | 149.31 | - |
Prepaid Expenses | 6.76 | 3.76 | 4.62 | 1.54 | - |
Other Current Assets | 13.21 | 2.64 | 8.29 | 18.8 | - |
Total Current Assets | 859.18 | 530.78 | 375.88 | 319.86 | - |
Property, Plant & Equipment | 199.72 | 187.12 | 188.22 | 146.95 | - |
Long-Term Investments | 72.61 | 5.72 | 0 | 0.94 | - |
Other Intangible Assets | 0.13 | 0.15 | 0.16 | 0.18 | - |
Long-Term Accounts Receivable | - | - | 5.03 | - | - |
Other Long-Term Assets | 39.51 | 65.15 | 65.28 | 38.11 | - |
Total Assets | 1,171 | 788.91 | 634.57 | 506.03 | - |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 115.45 | 167.13 | 140.99 | 134.07 | - |
Accrued Expenses | 13.48 | 19.92 | 11.83 | 5 | - |
Short-Term Debt | 169.6 | 198.85 | 138.87 | 113.45 | - |
Current Portion of Long-Term Debt | 1.36 | 14.6 | 13.18 | 24.85 | - |
Current Income Taxes Payable | 48.91 | 26.46 | 8.7 | 4.3 | - |
Other Current Liabilities | 10.08 | 12.52 | 9.32 | 10.62 | - |
Total Current Liabilities | 358.87 | 439.48 | 322.9 | 292.3 | - |
Long-Term Debt | 6.98 | 142.79 | 181.18 | 124.07 | - |
Pension & Post-Retirement Benefits | 11.35 | 3.1 | - | 1.8 | - |
Long-Term Deferred Tax Liabilities | 5.51 | 6.02 | 7.37 | 7.36 | - |
Other Long-Term Liabilities | 0 | - | - | - | - |
Total Liabilities | 382.71 | 591.39 | 511.45 | 425.52 | - |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 171.21 | 66.75 | 66.75 | 54.26 | - |
Additional Paid-In Capital | 434.68 | 14.78 | 14.78 | 14.78 | - |
Retained Earnings | 182.56 | 116 | 41.6 | 11.48 | - |
Comprehensive Income & Other | -0 | - | - | - | - |
Shareholders' Equity | 788.45 | 197.53 | 123.12 | 80.51 | - |
Total Liabilities & Equity | 1,171 | 788.91 | 634.57 | 506.03 | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 177.94 | 356.24 | 333.23 | 262.37 | - |
Net Cash (Debt) | -176.13 | -355.69 | -329.72 | -261.89 | - |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -12.76 | -53.29 | -49.40 | -49.50 | - |
Filing Date Shares Outstanding | 17.12 | 12.53 | 6.68 | 5.29 | - |
Total Common Shares Outstanding | 17.12 | 6.68 | 6.68 | 5.29 | - |
Working Capital | 500.31 | 91.3 | 52.98 | 27.56 | - |
Book Value Per Share | 46.05 | 29.59 | 18.45 | 15.22 | - |
Tangible Book Value | 788.31 | 197.38 | 122.96 | 80.33 | - |
Tangible Book Value Per Share | 46.04 | 29.57 | 18.42 | 15.18 | - |
Land | 99.71 | 72.34 | - | 31.75 | - |
Buildings | 28.57 | 28.53 | - | 24.58 | - |
Machinery | 136.53 | 141.96 | - | 128.05 | - |
Construction In Progress | 0.58 | 0.58 | - | 0.41 | - |